Get the Stockscreener App
42.96
0.67%
-0.29
After Hours:
42.95
-0.010
-0.02%
Cg Oncology Inc stock is traded at $42.96, with a volume of 654.21K.
It is down -0.67% in the last 24 hours and up +28.85% over the past month.
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.
See More
Previous Close:
$43.25
Open:
$43.25
24h Volume:
654.21K
Relative Volume:
0.69
Market Cap:
$3.28B
Revenue:
-
Net Income/Loss:
$-64.16M
P/E Ratio:
-33.82
EPS:
-1.2702
Net Cash Flow:
$-69.06M
1W Performance:
+12.67%
1M Performance:
+28.85%
6M Performance:
+122.82%
1Y Performance:
+19.04%
1-Day Range:
$42.22
$44.02
1-Week Range:
$37.43
$45.56
52-Week Range:
$14.80
$45.56
Cg Oncology Inc Stock (CGON) Company Profile
Name
Cg Oncology Inc
Sector
Industry
Phone
(949) 419-6203
Address
400 SPECTRUM CENTER DRIVE, IRVINE
Compare CGON with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CGON
Cg Oncology Inc
|
42.96 | 3.30B | 0 | -64.16M | -69.06M | -1.2702 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Cg Oncology Inc Stock (CGON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-08-25 | Initiated | Guggenheim | Buy |
| Aug-19-25 | Initiated | Piper Sandler | Overweight |
| Jul-10-25 | Resumed | Goldman | Buy |
| May-02-25 | Initiated | JP Morgan | Overweight |
| Apr-16-25 | Initiated | Scotiabank | Sector Perform |
| Jan-07-25 | Initiated | TD Cowen | Buy |
| Oct-24-24 | Initiated | UBS | Buy |
| Sep-23-24 | Initiated | RBC Capital Mkts | Outperform |
| Aug-28-24 | Initiated | ROTH MKM | Buy |
| Jun-28-24 | Initiated | BofA Securities | Buy |
| Feb-20-24 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-20-24 | Initiated | Goldman | Neutral |
| Feb-20-24 | Initiated | Morgan Stanley | Overweight |
| Feb-14-24 | Initiated | H.C. Wainwright | Buy |
View All
Cg Oncology Inc Stock (CGON) Latest News
Why retail investors favor CG Oncology Inc. stockLayoff News & Accurate Buy Signal Notifications - newser.com
Why CG Oncology Inc. stock is rated strong buyJuly 2025 Levels & Real-Time Stock Movement Alerts - newser.com
How to recover losses in CG Oncology Inc. stockJuly 2025 Patterns & Fast Exit and Entry Strategy Plans - newser.com
James Mulay Sells 5,903 Shares of CG Oncology (NASDAQ:CGON) Stock - MarketBeat
CG Oncology (NASDAQ:CGON) Research Coverage Started at Guggenheim - Defense World
Midday Stock Roundup: EnVVeno down 15% - Orange County Business Journal
CG Oncology (NASDAQ:CGON) Reaches New 1-Year HighHere's What Happened - MarketBeat
CG Oncology (NASDAQ:CGON) Now Covered by Analysts at Guggenheim - MarketBeat
Is this a good reentry point in CG Oncology Inc.2025 Institutional Moves & Fast Gaining Stock Strategy Reports - newser.com
Candlestick signals on CG Oncology Inc. stock todayJuly 2025 Trade Ideas & AI Enhanced Execution Alerts - newser.com
CG Oncology (NASDAQ:CGON) Receives "Sell (D-)" Rating from Weiss Ratings - MarketBeat
CG Oncology (CGON): Assessing Valuation Following Analyst Coverage and Positive Phase 3 Trial Results - Yahoo Finance
CG Oncology: Upgraded, Rising, But Should We Still Be Optimistic? (NASDAQ:CGON) - Seeking Alpha
CG Oncology’s Surging Prospects: Buy or Hold? - StocksToTrade
When is the best time to exit CG Oncology Inc.Stop Loss & Expert Verified Movement Alerts - newser.com
CG Oncology Inc. recovery potential after sell offJuly 2025 Decliners & Growth Oriented Trading Recommendations - newser.com
Price momentum metrics for CG Oncology Inc. explainedJuly 2025 Price Swings & AI Based Buy and Sell Signals - newser.com
Ranking CG Oncology Inc. among high performing stocks via toolsLong Setup & Accurate Entry/Exit Alerts - newser.com
Why Cg Oncology Stock Rocketed 7% Higher Today - The Globe and Mail
Why Cg Oncology Stock Rocketed 7% Higher Today - The Motley Fool
CG Oncology (NASDAQ:CGON) Trading 7.1% HigherHere's What Happened - MarketBeat
CG Oncology stock initiated Buy at Guggenheim (CGON:NASDAQ) - Seeking Alpha
Guggenheim Initiates Coverage of CG Oncology (CGON) with Buy Recommendation - Nasdaq
Guggenheim Initiates Coverage on CG Oncology With Buy Rating, $90 Price Target - MarketScreener
CG Oncology Announces Promising Phase 3 Trial Results - MSN
Applying Elliott Wave Theory to CG Oncology Inc.Portfolio Profit Report & Verified Swing Trading Watchlists - newser.com
What’s next for CG Oncology Inc. stock priceProduct Launch & High Return Trade Opportunity Guides - newser.com
How CG Oncology Inc. stock reacts to bond yieldsQuarterly Profit Summary & Long-Term Capital Growth Ideas - newser.com
How to monitor CG Oncology Inc. with trend dashboardsJuly 2025 Update & Safe Entry Point Alerts - newser.com
Will a bounce in CG Oncology Inc. offer an exitJuly 2025 Institutional & Long-Term Investment Growth Plans - newser.com
How analysts rate CG Oncology Inc. stock today2025 Trade Ideas & Technical Confirmation Trade Alerts - newser.com
CG Oncology (NASDAQ:CGON) Upgraded to Hold at Wall Street Zen - Defense World
CG Oncology (NASDAQ:CGON) Raised to "Hold" at Wall Street Zen - MarketBeat
NMIBC Market to Experience Notable Growth in Forecast Span - openPR.com
Best data tools to analyze CG Oncology Inc. stockQuarterly Trade Summary & Low Drawdown Trading Strategies - newser.com
Can you recover from losses in CG Oncology Inc.2025 Technical Overview & Fast Entry High Yield Stock Tips - newser.com
AMI Asset Management Corp Purchases New Stake in CG Oncology, Inc. $CGON - MarketBeat
CG Oncology (NASDAQ:CGON) Director Leonard Post Sells 5,000 Shares of Stock - MarketBeat
Cg Oncology stock hits 52-week high at 40.49 USD By Investing.com - Investing.com Nigeria
Cg Oncology stock hits 52-week high at 40.49 USD - Investing.com
Cg Oncology Inc Stock (CGON) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):